Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Transcept Pharmaceuticals, Inc. (TSPT)

-NasdaqGM
2.98 Up 0.05(1.67%) Apr 17, 3:59PM EDT
|After Hours : 2.93 Down 0.05 (1.68%) Apr 17, 5:53PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 316   468   481   482  
Cost of Revenue140  86  283  6,312  
Gross Profit 176   382   198   (5,830)
Operating Expenses
Research Development1,753  2,410  898  1,843  
Selling General and Administrative3,941  2,658  3,030  2,802  
Non Recurring -   -  2,962   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (5,518) (4,686) (6,692) (10,475)
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes(5,535)(4,703)(6,708)(10,500)
Interest Expense -   -   -   -  
Income Before Tax(5,535)(4,703)(6,708)(10,500)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(5,535)(4,703)(6,708)(10,500)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (5,535) (4,703) (6,708) (10,500)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (5,535) (4,703) (6,708) (10,500)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.